Kirsty 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
IAIN/0013 
B.II.b.2.c.1 - Change to importer, batch release 
30/11/2023 
Annex II and 
arrangements and quality control testing of the FP - 
PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
T/0012 
Transfer of Marketing Authorisation 
03/08/2023 
30/08/2023 
SmPC, 
Labelling and 
PL 
IB/0009 
B.II.b.4.f - Change in the batch size (including batch 
14/07/2023 
n/a 
size ranges) of the finished product - The scale for a 
biological/immunological medicinal product is 
increased/decreased without process change (e.g. 
duplication of line) 
IB/0011 
B.I.b.2.e - Change in test procedure for AS or 
07/07/2023 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
N/0010 
Minor change in labelling or package leaflet not 
17/05/2023 
30/08/2023 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/1749/
Periodic Safety Update EU Single assessment - 
14/04/2023 
n/a 
PRAC Recommendation - maintenance 
202209 
insulin aspart 
PSUSA/1749/
Periodic Safety Update EU Single assessment - 
05/05/2022 
n/a 
PRAC Recommendation - maintenance 
202109 
insulin aspart 
IA/0007 
A.4 - Administrative change - Change in the name 
18/03/2022 
n/a 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
Page 2/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II/0003/G 
This was an application for a group of variations. 
13/01/2022 
n/a 
B.II.e.1.a.3 - Change in immediate packaging of the 
finished product - Qualitative and quantitative 
composition - Sterile medicinal products and 
biological/immunological medicinal products 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
IA/0006/G 
This was an application for a group of variations. 
21/12/2021 
n/a 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
IAIN/0004/G 
This was an application for a group of variations. 
06/12/2021 
n/a 
B.I.e.3 - Deletion of an approved change 
management protocol related to the AS 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0002 
B.IV.1.z - Change of a measuring or administration 
12/10/2021 
n/a 
Page 3/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
device - Other variation 
IAIN/0001 
A.2.a - Administrative change - Change in the 
16/07/2021 
22/07/2022 
SmPC, Annex 
To change the invented name of the medicinal product from 
(invented) name of the medicinal product for CAPs 
II, Labelling 
Kixelle to Kirsty. 
and PL 
Page 4/4 
 
 
 
 
 
 
 
 
